🌍 Global & Macro Backdrop Overnight, U.S. markets posted gains supported by expectations of rate cuts and strong earnings. In Asia, markets are mixed — China and Japan are steady, while Southeast Asia sees mild gains. Commodity prices are cooling slightly: Crude slipped amid OPEC hints at easing supply constraints, and base metals are softer […]
🌍 Global Cues Overnight, U.S. markets closed higher, bolstered by optimism over future rate cuts and easing trade fears. In Asia, mixed action persists — some markets rallying on global cues, others holding back on macro uncertainties. One key point: India VIX surged ~6% to ~11.42 in early trade previews, showing that market participants are
🌍 Global & Macro Signals Overnight, global markets faced pressure as renewed tariff announcements from the U.S. rattled sentiment, especially in Asia. Reuters notes new U.S. tariffs announced by President Trump on a range of goods and slowing expectations of aggressive cuts by the Fed. The Indian rupee remains vulnerable amid continued foreign outflows and
🌍 Global & Macro Cue Global markets are trading with caution. U.S. indices ended lower last night as traders booked profits ahead of key inflation data. Asian markets are mixed this morning, with China showing slight weakness while Japan and South Korea remain range-bound. On the currency side, the Indian rupee is still pinned close
🌍 Global Key Cues & Macro Snapshot 🧭 The global setup remains mixed ahead of Indian market opening: 📉 US Markets: Dow Jones and Nasdaq showed mild weakness on tech profit-taking. 🏦 Fed Policy: Recent rate cuts continue to buoy emerging markets, with inflows expected in Asia. 💱 Currency Trends: Dollar Index stable near 105,
🌍 Global Key Cues Overseas markets will drive India’s opening tone. US indices showed mixed sentiment after Fed commentary. Asian markets are cautious on crude volatility. European futures are flat, waiting for macro updates. Global yields, dollar movement, and geopolitical headlines remain the top watchpoints. 📈 GIFT Nifty Status Current outlook: Flat to mildly cautious
